Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.
about
Studying Cellular Signal Transduction with OMIC TechnologiesIntegrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancerLoss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancerProteomics and peptidomics: moving toward precision medicine in urological malignanciesAnalytics for Metabolic EngineeringReverse phase protein arrays in signaling pathways: a data integration perspectiveEmerging protein array technologies for proteomicsFacing current quantification challenges in protein microarraysQuantitative phenotypic and pathway profiling guides rational drug combination strategiesThe proteomic landscape of triple-negative breast cancer.Reverse Phase Protein Arrays-Quantitative Assessment of Multiple Biomarkers in Biopsies for Clinical UseThe ZNF304-integrin axis protects against anoikis in cancerReverse phase protein microarrays advance to use in clinical trialsIntegrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line setUdp-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancerInferring causal molecular networks: empirical assessment through a community-based effortPerturbation biology: inferring signaling networks in cellular systemsPhosphorylation site dynamics of early T-cell receptor signalingA Crowdsourcing Approach to Developing and Assessing Prediction Algorithms for AML PrognosisSemi-quantitative measurement of specific proteins in human cumulus cells using reverse phase protein arrayMinireview: progress and challenges in proteomics data management, sharing, and integrationEvidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomasCharacterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristicsFunction-Blocking ERBB3 Antibody Inhibits the Adaptive Response to RAF InhibitorA community effort to assess and improve drug sensitivity prediction algorithms.Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cellsFunctional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapyNetwork analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axisMesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearancePiHelper: an open source framework for drug-target and antibody-target data.TCPA: a resource for cancer functional proteomics dataomicsNPC: Applying the Non-Parametric Combination Methodology to the Integrative Analysis of Heterogeneous Omics Data.A comprehensive comparison of normalization methods for loading control and variance stabilization of reverse-phase protein array data.Sparse Bayesian Graphical Models for RPPA Time Course Data.Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.BAYESIAN SPARSE GRAPHICAL MODELS FOR CLASSIFICATION WITH APPLICATION TO PROTEIN EXPRESSION DATA.A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway.Improving Cancer Gene Expression Data Quality through a TCGA Data-Driven Evaluation of Identifier Filtering.Reverse-phase protein lysate microarrays for cell signaling analysis.RPPAML/RIMS: a metadata format and an information management system for reverse phase protein arrays.
P2860
Q24289429-64290C1E-E58C-4105-9106-7C403D404B3FQ24633201-AAB5588D-7FB0-4FF6-929D-3CB50C8E23D1Q24653934-B386663B-38F8-4304-A20B-50CDAE8BE02DQ26749401-22A02434-ABFD-4115-92E5-D2E3251A7DADQ26781070-CF57CB48-1376-44E9-9F45-5EAEDDC83380Q26799716-69D96AAC-583F-4EEF-B5A9-AD9876A612F5Q26824107-9E3E2D29-38DC-4CF0-BFD4-90F196EE0AF2Q26864708-A4842E17-4647-41CE-80EF-B3819F7D028CQ27021150-1581B488-701A-445D-B14E-281F6FA0A0C8Q27320721-1069B8F0-47A0-4302-A3A3-93524382F3F4Q28083256-B567EFE1-C5BE-4FC0-87E4-4736CE804018Q28115264-AB73BFCD-4B15-4564-B962-7E63886144BDQ28384553-9BDB6219-A5F0-4470-B8AC-752297378645Q28389579-63E831A4-9518-4813-8018-26CE157EE475Q28392741-13055BAF-D6F6-4A9C-82A3-7D17CB26069AQ28530068-B33B100E-4E59-459A-B66F-C6297425E047Q28537769-4D4B8651-5087-4FC6-804D-DE994293B465Q28542511-3713766A-8194-4F72-A149-4A94416F9D8DQ28597169-9FCA8D92-6B64-4E18-BE85-30601BBB4274Q28657731-E0170DE1-F332-461B-92C5-D5A3818EBCB8Q28727478-09557AA1-1004-411F-B7B9-465367CD38D5Q28728855-847F93A3-B0B2-4649-BE06-CC8BEB861E95Q28751743-879852C5-1EF5-4EC2-8767-17071B7FCA6FQ29542169-EB38EF43-A0EE-4BBB-B257-2FE42A23A9EDQ30371323-39804F1B-6697-45B3-8FDF-602DE4743471Q30493785-FF1720A8-A2C3-4FCE-BA15-1750B3814987Q30494709-3270CE37-D375-4A5D-BB1F-37C249808560Q30536784-39911937-A7D4-484E-BA70-7E0283C17C39Q30579225-470F76B2-C383-45E1-922F-55591BF2252FQ30648106-EF81DE55-9B26-4E0E-A179-208A562605A8Q30666936-724A8B12-182A-4472-801C-E5A2E8141D54Q30827406-F1EF4481-1614-4C0D-A596-2D9864CC98EFQ30867943-3B59F27E-EBC7-4340-BB10-A6476463A480Q30928909-1DEAB700-E801-42F7-8EDB-68C4F0F3327DQ30966966-0C309582-F7B3-47AF-8535-220105A4B671Q30985471-C72B4261-EB9F-4BA7-BAB5-C269689B498DQ31010361-38B8384B-F02A-4725-BE77-D5EEEAFA4B55Q31034425-6154ACFE-1A00-4399-B307-9E64BCB4D0DEQ33381529-61CEA73E-0FDE-4E71-A5B3-7F9D9B0C7B7BQ33395131-7B57F758-B8CF-4051-A2D2-77C221DE1E8F
P2860
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Reverse phase protein array: v ...... and hematopoietic stem cells.
@en
type
label
Reverse phase protein array: v ...... and hematopoietic stem cells.
@en
prefLabel
Reverse phase protein array: v ...... and hematopoietic stem cells.
@en
P2093
P1476
Reverse phase protein array: v ...... and hematopoietic stem cells.
@en
P2093
Bryan Hennessy
Gordon B Mills
Raoul Tibes
Steven M Kornblau
P304
P356
10.1158/1535-7163.MCT-06-0334
P577
2006-10-01T00:00:00Z